MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Mizuho cuts target for MetLife stock from USD 112 to USD 109

Analyst downgrade Dividend AI-generated analysis

πŸ“‰ Mizuho cuts MetLife price target from USD 112.00 to USD 109.00 while retaining an Outperform rating.

πŸ“ˆ MetLife reported Q2 2026 adjusted EPS of USD 2.43, representing a 20% year-over-year increase.

πŸ’° Adjusted earnings grew 15% to USD 1.6 billion with an adjusted return on equity of 17%.

πŸ“… MetLife declared a Q4 dividend of USD 0.59 per share payable on December 8, 2026.

⚠️ Management expects favorable group-life mortality ratios to normalize after a recent quarterly low of 79%.

🏒 MetLife holds a market cap of USD 63.4 billion and trades near its yearly high.

πŸ“… Q3 2026 results are scheduled for release on November 4, 2026, followed by a conference call.

πŸ“Š The stock trades at EUR 87.89 as of October 9, 2026, slightly up from the prior close.

Bullish Signals
  • MetLife reported adjusted earnings per share of USD 2.43 for Q2 2026, a 20% year-over-year increase.
  • Adjusted earnings rose 15% to USD 1.6 billion with an adjusted return on equity reaching 17%.
  • The company declared a fourth-quarter dividend of USD 0.59 per share payable in December 2026.
  • MetLife achieved the top end of its annual target range for adjusted return on equity at 17%.
Risk Factors
  • Mizuho lowered its price target from USD 112 to USD 109, signaling analyst caution despite recent earnings beats.
  • Group-life mortality ratios normalized from a favorable quarterly low of 79%, which was below the 83%-88% annual target range.
Full Analysis
Mizuho Securities has lowered its price target for MetLife Inc. (MET) from USD 112 to USD 109, maintaining an Outperform rating. This revision reflects a cautious outlook despite the company's recent financial performance, with the new target remaining above the current trading price of approximately EUR 87.89 as of October 9, 2026. MetLife reported strong second-quarter results in 2026, with adjusted earnings per share rising 20% year-over-year to USD 2.43 and total adjusted earnings increasing 15% to USD 1.6 billion. The company achieved an adjusted return on equity of 17%, hitting the top end of its annual target range, while also declaring a fourth-quarter dividend of USD 0.59 per share. Management noted that favorable group-life mortality ratios are expected to normalize after a recent quarterly figure of 79%, which was below the company's 2026 target range of 83% to 88%. Investors will watch the upcoming third-quarter earnings release on November 4, 2026, for further confirmation of the company's trajectory and capital-return strategy. MetLife currently holds a market capitalization of USD 63.4 billion and trades within a 52-week range of USD 67.33 to USD 100.93. The stock is listed on the NYSE in the Financial Services sector, specifically Life Insurance, and continues to be a key focus for analysts monitoring its mortality trends and capital management.